Stay updated on Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.

Latest updates to the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe webpage has been updated to include information about a new clinical trial for a micellar formulation of Docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC), while significant details about previous treatment methods and their drawbacks have been removed.SummaryDifference42%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check78 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.